All Stories

  1. Update in Lung Cancer 2015
  2. An Official American Thoracic Society/American College of Chest Physicians Policy Statement: Implementation of Low-Dose Computed Tomography Lung Cancer Screening Programs in Clinical Practice
  3. The 2015 World Health Organization Classification of Lung Tumors
  4. An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management
  5. Limited Resection Versus Lobectomy for Older Patients With Early-Stage Lung Cancer: Impact of Histology
  6. Update in Lung Cancer 2014
  7. Outcomes after Stereotactic Body Radiotherapy versus Limited Resection in Older Patients with Early-Stage Lung Cancer
  8. The Non–Small Cell Lung Cancer Immune Contexture. A Major Determinant of Tumor Characteristics and Patient Outcome
  9. Components Necessary for High-Quality Lung Cancer Screening
  10. Integrative Analysis of DNA Methylation and Gene Expression Data Identifies EPAS1 as a Key Regulator of COPD
  11. Association of Patient–Provider Communication Domains with Lung Cancer Treatment
  12. Cultural Factors Associated with Racial Disparities in Lung Cancer Care
  13. Genome-Wide Study of Percent Emphysema on Computed Tomography in the General Population. The Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource Study
  14. Molecular testing guidelines for lung adenocarcinoma: Utility of cell blocks and concordance between fine-needle aspiration cytology and histology samples
  15. Comparative Anatomy of Chromosomal Domains with Imprinted and Non-Imprinted Allele-Specific DNA Methylation
  16. An Official American Thoracic Society/European Respiratory Society Statement: The Role of the Pulmonologist in the Diagnosis and Management of Lung Cancer
  17. APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema
  18. Update in Lung Cancer and Mesothelioma 2012
  19. Molecular Biology of Lung Cancer
  20. Evaluating Beliefs Associated with Late-Stage Lung Cancer Presentation in Minorities
  21. PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells
  22. Racial and Ethnic Differences in Beliefs About Lung Cancer Care
  23. Thymidylate synthase expression and molecular alterations in adenosquamous carcinoma of the lung
  24. Acquisition and Processing of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Specimens in the Era of Targeted Lung Cancer Chemotherapy
  25. Do all lung adenocarcinomas follow a stepwise progression?
  26. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: International Multidisciplinary Classification of Lung Adenocarcinoma: Executive Summary
  27. Progression of Human Bronchioloalveolar Carcinoma to Invasive Adenocarcinoma Is Modeled in a Transgenic Mouse Model of K-ras-Induced Lung Cancer by Loss of the TGF-  Type II Receptor
  28. Update in Lung Cancer and Oncological Disorders 2010
  29. Lung cancer physicians' referral practices for palliative care consultation
  30. Patients rate physician communication about lung cancer
  31. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
  32. Lysyl oxidase: A lung adenocarcinoma biomarker of invasion and survival
  33. Computer-aided diagnosis of pulmonary nodules using a two-step approach for feature selection and classifier ensemble construction
  34. Molecular Testing in Lung Cancer: The Time Is Now
  35. Pathologic Diagnosis of Advanced Lung Cancer Based on Small Biopsies and Cytology: A Paradigm Shift
  36. TGF-² Signaling Pathway in Lung Adenocarcinoma Invasion
  37. Effectiveness of Radiation Therapy for Elderly Patients with Unresected Stage I and II Non–Small Cell Lung Cancer
  38. The Gender-Specific Aspects of Lung Cancer
  39. Rounding Up Apoptosis Resistance Targets in Lung Cancer
  40. Update in Lung Cancer 2008
  41. Genomics of Lung Cancer
  42. Invasive Size is an Independent Predictor of Survival in Pulmonary Adenocarcinoma
  43. Comparison of image features calculated in different dimensions for computer-aided diagnosis of lung nodules
  44. Impact of segmentation uncertainties on computer-aided diagnosis of pulmonary nodules
  45. A Two-Step Approach for Feature Selection and Classifier Ensemble Construction in Computer-Aided Diagnosis
  46. Update in Lung Cancer 2007
  47. Waiting to Exhale
  48. No effect of cigarette smoking dose on oxidized plasma proteins
  49. Plasma carbonyls do not correlate with lung function or computed tomography measures of lung density in older smokers
  50. Lung adenocarcinoma invasion in TGFβRII-deficient cells is mediated by CCL5/RANTES
  51. A 10-Gene Classifier for Distinguishing Head and Neck Squamous Cell Carcinoma and Lung Squamous Cell Carcinoma
  52. Update in Lung Cancer 2006
  53. Expression of the cytoskeleton linker protein ezrin in human cancers
  54. Clinical Predictors of Metastatic Disease to the Brain from Non–Small Cell Lung Carcinoma: Primary Tumor Size, Cell Type, and Lymph Node Metastases 1
  55. Expression Profiling and Lung Cancer Development
  56. Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin–proteasome pathway as a therapeutic target in poor prognosis tumors
  57. The Epithelial Cell in Lung Health and Emphysema Pathogenesis
  58. Epigenetic Inactivation of Betaig-h3 Gene in Human Cancer Cells
  59. Lung Adenocarcinoma Global Profiling Identifies Type II Transforming Growth Factor-β Receptor as a Repressor of Invasiveness
  60. P16 Loss and Mitotic Activity Predict Poor Survival in Patients with Peritoneal Malignant Mesothelioma
  61. CDX2 Immunostaining as a Gastrointestinal Marker
  62. Utility of CD138 (syndecan-1) in distinguishing carcinomas from mesotheliomas
  63. STRUCTURAL EMPHYSEMA DOES NOT CORRELATE WITH LUNG COMPLIANCE: LESSONS FROM THE MOUSE SMOKING MODEL
  64. Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma
  65. The Heparan Sulfate ProteoglycanGPC3Is a Potential Lung Tumor Suppressor
  66. Gene Expression in Lung Adenocarcinomas of Smokers and Nonsmokers
  67. Patterns of allelic loss differ in lung adenocarcinomas of smokers and nonsmokers